Cleared Traditional

K011057 - INTERCEPT ORAL FLUID DRUG TEST ORAL SPECIMEN COLLECTION DEVICE, MODEL 503-XXXX

K011057 is an FDA 510(k) clearance for INTERCEPT ORAL FLUID DRUG TEST ORAL SPE..., manufactured by OraSure Technologies, Inc.. The device is a Class 2 Toxicology device with product code PJD cleared through the Traditional 510(k) pathway after a 61-day FDA review.

K011057 · OraSure Technologies, Inc. · Toxicology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2001
Decision
61d
Days
Class 2
Risk

K011057 is an FDA 510(k) clearance for the INTERCEPT ORAL FLUID DRUG TEST ORAL SPECIMEN COLLECTION DEVICE, MODEL 503-XXXX. Classified as Oral Fluid Drugs Of Abuse And Alcohol Test Specimen Collection Device (product code PJD), Class II - Special Controls.

Submitted by OraSure Technologies, Inc. (Bethlehem, US). The FDA issued a Cleared decision on June 6, 2001 after a review of 61 days - a notably fast clearance cycle.

This device falls under the Toxicology FDA review panel, regulated under 21 CFR 862.1675 - the FDA toxicology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all OraSure Technologies, Inc. devices

FDA 510(k) Submission Details - K011057

510(k) Number K011057 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 06, 2001
Decision Date June 06, 2001
Days to Decision 61 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
26d faster than avg
Panel avg: 87d · This submission: 61d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

PJD Device Classification - Class 2, Special Controls

Product Code PJD Oral Fluid Drugs Of Abuse And Alcohol Test Specimen Collection Device
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1675
Definition Intended For Use In The Collection, Preservation, And Transport Of Oral Fluid Specimens For Drugs Of Abuse Or Alcohol Testing.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Toxicology devices follow this clearance model.

Regulatory Peers - PJD Oral Fluid Drugs Of Abuse And Alcohol Test Specimen Collection Device

All 7
Devices cleared under the same product code (PJD) and FDA review panel - the closest regulatory comparables to K011057.
Quantisal™ II Oral Fluid Collection Device
K223781 · Immunalysis Corporation · Jul 2023
Quantisal Oral Fluid Collection Device
K200801 · Immunalysis Corporation · Jul 2020
Quantisal II Oral Fluid Collection Device
K183048 · Immunalysis Corporation · Jul 2019
ORAL-EZE ORAL FLUID COLLECTION SYSTEM
K984361 · Osborn Laboratories, Inc. · Jan 1999
EPISCREEN ORAL SPECIMEN COLLECTION DEVICE
K973395 · Epitope, Inc. · Feb 1998
EPISCREEN
K970357 · Epitope, Inc. · Mar 1997